H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Viking Therapeutics (VKTX – Research Report) today and set a price target ...
1d
Hosted on MSNScotiabank Initiates Coverage of Viking Therapeutics (VKTX) with Sector Outperform RecommendationFintel reports that on February 13, 2025, Scotiabank initiated coverage of Viking Therapeutics (NasdaqCM:VKTX) with a Sector ...
Weight-loss drugs have been popular over the past couple of years, and Hims & Hers Health Inc (NYSE:HIMS), Novo Nordisk A/S ( NYSE:NVO), and Viking Therapeutics Inc (NASDAQ:VKTX) are among the most ...
Scotiabank initiated coverage of Viking Therapeutics (VKTX) with an Outperform rating and $102 price target Maximize Your Portfolio with Data ...
Analysts at HC Wainwright issued their Q1 2025 earnings per share estimates for Viking Therapeutics in a research note issued on Thursday, February 6th. HC Wainwright analyst J. Pantginis expects that ...
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...
Viking Therapeutics VKTX has outperformed the market over the past 5 years by 22.07% on an annualized basis producing an ...
We recently published an article titled These 10 Companies Led Monday’s Downturn. In this article, we are going to take a ...
Novo Nordisk faces challenges but its pipeline remains strong. Find out why NVO stock could deliver high double-digit returns ...
Healthcare stocks have something to offer every investor. If you're looking for high growth, you can try an innovative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results